Tideglusib, a chemical inhibitor of GSK3β, attenuates hypoxic-ischemic brain injury in neonatal mice
Abstract
Background Hypoxia-ischemia is an important cause of brain injury and neurological morbidity in the newborn infants. The activity of glycogen synthase kinase-3β (GSK-3β) is up-regulated following neonatal stroke. Tideglusib is a GSK-3β inhibitor which has neuroprotective effects against neurodegenerative diseases in clinical trials. However, the effect of tideglusib on hypoxic-ischemic (HI) brain injury in neonates is still unknown.Methods Postnatal day 7 (P7) mouse pups subjected to unilateral common carotid artery ligation followed by 1h of hypoxia or sham surgery was performed. HI animals were administered tideglusib (5mg/kg) or vehicle intraperitoneally 20min prior to the onset of ischemia. The brain infarct volume and whole brain images, were used in conjunction with Nissl staining to evaluate the protective effects of tideglusib. Protein levels of glial fibrillary acidic protein (GFAP), Notch1, cleaved caspase-3/9, phosphorylated signal transducer and activator of transcription 3 (STAT3), GSK-3β and protein kinase B (Akt) were detected to identify potentially involved molecules.Results Tideglusib significantly reduced cerebral infarct volume at both 24h and 7days after HI injury. Tideglusib also increased phosphorylated GSK-3β(Ser9) and Akt(Ser473), and reduced the expression of GFAP and p-STAT3(Tyr705). In addition, pretreatment with tideglusib also enhanced the protein level of Notch1. Moreover, tideglusib reduced the cleavage of pro-apoptotic signal caspase proteins, including caspase 3 and caspase 9 following HI.Conclusion These results indicate that tideglusib shows neuroprotection against hypoxic-ischemic brain injury in neonatal mice.General significance Tideglusib is a potential compound for the prevention or treatment of hypoxic-ischemic brain injury in neonates.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Tideglusib has been reported to reduce tau phosphorylation and has anti-inflammatory effects in animal models.
“Tideglusib has been reported to reduce tau phosphorylation and has anti-inflammatory effects in animal models [216, 217].”
From Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation (2023) · cites this paper as [217]
Cites
1 retracted
Li, L., Klebe, D. W., Doycheva, D. M., McBride, D. W., Krafft, P. R., Flores, J. J., Zhou, C., Zhang, J. H., & Tang, J. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.10.004 · Cited by 38 · see citing works
RetractedNotch Signaling: Cell Fate Control and Signal Integration in Development
Artavanis-Tsakonas, S., Rand, M. D., & Lake, R. J. (1999) · Science · doi:10.1126/science.284.5415.770 · Cited by 5,909 · see citing works
Reactive Gliosis and the Multicellular Response to CNS Damage and Disease
Burda, J. E., & Sofroniew, M. V. (2014) · Neuron · doi:10.1016/j.neuron.2013.12.034 · Cited by 1,431 · see citing works
Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
Stambolic, V., Ruel, L., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70790-2 · Cited by 1,321 · see citing works
Glial fibrillary acidic protein: From intermediate filament assembly and gliosis to neurobiomarker
Yang, Z., & Wang, K. K. W. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.04.003 · Cited by 1,050 · see citing works
Green, D. R. (2000) · Cell · doi:10.1016/s0092-8674(00)00003-9 · Cited by 1,011 · see citing works
Wanner, I. B., Anderson, M. A., Song, B., Levine, J., Fernandez, A., Gray-Thompson, Z., Ao, Y., & Sofroniew, M. V. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2121-13.2013 · Cited by 839 · see citing works
GSK3 signalling in neural development
Hur, E., & Zhou, F. (2010) · Nature reviews. Neuroscience · doi:10.1038/nrn2870 · Cited by 828 · see citing works
Hypoxic-Ischemic Encephalopathy: A Review for the Clinician
Douglas-Escobar, M., & Weiss, M. D. (2015) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2014.3269 · Cited by 778 · see citing works
Mao, Y., Ge, X., Frank, C. L., Madison, J. M., Koehler, A. N., Doud, M. K., Tassa, C., Berry-Scott, E., Soda, T., Singh, K. K., et al. (2009) · Cell · doi:10.1016/j.cell.2008.12.044 · Cited by 768 · see citing works
A Phase II Trial of Tideglusib in Alzheimer's Disease
Lovestone, S., for the ARGO investigators, Boada, M., Dubois, B., Hüll, M., Rinne, J. O., Huppertz, H.-J., Calero, M., Andrés, M. V., Gómez-Carrillo, B., et al. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-141959 · Cited by 536 · see citing works
Akt Regulates Cell Survival and Apoptosis at a Postmitochondrial Level
Zhou, H., Li, X., Meinkoth, J. L., & Pittman, R. N. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.3.483 · Cited by 511 · see citing works
Apoptosis Has a Prolonged Role in the Neurodegeneration after Hypoxic Ischemia in the Newborn Rat
Nakajima, W., Ishida, A., Lange, M. S., Gabrielson, K. L., Wilson, M. A., Martin, L. J., Blue, M. E., & Johnston, M. V. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-21-07994.2000 · Cited by 421 · see citing works
Neuronal cell death in neonatal hypoxia‐ischemia
Northington, F. J., Chavez‐Valdez, R., & Martin, L. J. (2011) · Annals of Neurology · doi:10.1002/ana.22419 · Cited by 378 · see citing works
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
Eldar-Finkelman, H., & Martı́nez, A. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00032 · Cited by 356 · see citing works
Minocycline markedly protects the neonatal brain against hypoxic‐ischemic injury
Arvin, K. L., Han, B., Du, Y.-S., Lin, S.-Z., Paul, S. M., & Holtzman, D. (2002) · Annals of Neurology · doi:10.1002/ana.10242 · Cited by 323 · see citing works
A phase 2 trial of the GSK‐3 inhibitor tideglusib in progressive supranuclear palsy
Tolosa, E., Litvan, I., Höglinger, G. U., Burn, D., Lees, A., Andrés, M. V., Gómez‐Carrillo, B., León, T., del Ser, T., & for the TAUROS Investigators (2014) · Movement Disorders · doi:10.1002/mds.25824 · Cited by 320 · see citing works
Prentice, H. M., Modi, J. P., & Wu, J. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/964518 · Cited by 256 · see citing works
Evidence for Irreversible Inhibition of Glycogen Synthase Kinase-3β by Tideglusib
Domı́nguez, J. M., Fuertes, A., Orozco, L., del Monte-Millán, M., Delgado, E., & Medina, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.306472 · Cited by 249 · see citing works
Stump, G., Durrer, A., Klein, A.-L., Lütolf, S., Suter, U., & Taylor, V. (2002) · Mechanisms of Development · doi:10.1016/s0925-4773(02)00043-6 · Cited by 248 · see citing works
Ethanol-induced neuronal apoptosis in vivo requires BAX in the developing mouse brain
Young, C., Klocke, B. J., Tenkova, T. I., Choi, J., Labruyere, J., Qin, Y.-Q., Holtzman, D. M., Roth, K. A., & Olney, J. W. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401277 · Cited by 201 · see citing works
Mitofusin 2 Triggers Vascular Smooth Muscle Cell Apoptosis via Mitochondrial Death Pathway
Guo, X., Chen, K., Guo, Y., Liao, H., Tang, J., & Xiao, R. (2007) · Circulation Research · doi:10.1161/circresaha.107.157644 · Cited by 199 · see citing works
Endo, H., Nito, C., Kamada, H., Nishi, T., & Chan, P. H. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600303 · Cited by 193 · see citing works
Chuang, D., Wang, Z., & Chiu, C. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00015 · Cited by 171 · see citing works
Does perinatal asphyxia impair cognitive function without cerebral palsy?
Gonzalez, F. F., & Miller, S. P. (2006) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/adc.2005.092445 · Cited by 167 · see citing works
Glycogen Synthase Kinase 3 Inhibition Promotes Adult Hippocampal Neurogenesis in Vitro and in Vivo
Morales-Garcia, J. A., Luna‐Medina, R., Alonso‐Gil, S., Sanz-SanCristóbal, M., Palomo, V., Gil, C., Santos, Á., Martı́nez, A., & Pérez‐Castillo, A. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300110c · Cited by 162 · see citing works
Astrocyte activation is suppressed in both normal and injured brain by FGF signaling
Kang, W., Balordi, F., Su, N. Y., Chen, L., Fishell, G., & Hébert, J. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320401111 · Cited by 159 · see citing works
Gill, R., Soriano, M. A., Blomgren, K., Hagberg, H., Wybrect, R., Miss, M.-T., Hoefer, S., Adam, G., Niederhauser, O., Kemp, J. A., et al. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200204000-00006 · Cited by 152 · see citing works
TRPM7 inhibitor carvacrol protects brain from neonatal hypoxic-ischemic injury
Chen, W., Xu, B., Xiao, A.-J., et al. (2015) · Molecular Brain · doi:10.1186/s13041-015-0102-5 · Cited by 140 · see citing works
Amyloid Burden, Neuroinflammation, and Links to Cognitive Decline After Ischemic Stroke
Thiel, A., Cechetto, D. F., Heiss, W., Hachinski, V., & Whitehead, S. N. (2014) · Stroke · doi:10.1161/strokeaha.114.004285 · Cited by 139 · see citing works
Puka‐Sundvall, M., Wallin, C., Gilland, E., Hallin, U., Wang, X., Sandberg, M., Karlsson, J.-O., Blomgren, K., & Hagberg, H. (2000) · Developmental Brain Research · doi:10.1016/s0165-3806(00)00111-5 · Cited by 134 · see citing works
Ueno, Y., Chopp, M., Zhang, L., Buller, B., Liu, Z., Lehman, N. L., Liu, X., Zhang, Y., Roberts, C. J., & Zhang, Z. G. (2012) · Stroke · doi:10.1161/strokeaha.111.646224 · Cited by 134 · see citing works
The possible role of the Akt signaling pathway in schizophrenia
Zheng, W., Wang, H., Zeng, Z., Lin, J., Little, P. J., Srivastava, L. K., & Quirion, R. (2012) · Brain Research · doi:10.1016/j.brainres.2012.06.032 · Cited by 129 · see citing works
Self-citationMartı́nez, A., Alonso, M., Castro, A., Dorronsoro, I., Gelpí, J. L., Luque, F. J., Pérez, C., & Moreno, F. J. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040895g · Cited by 127 · see citing works
Ek, C. J., D’Angelo, B., Baburamani, A. A., Lehner, C., Leverin, A., Smith, P. L. P., Nilsson, H., Svedin, P., Hagberg, H., & Mallard, C. E. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.255 · Cited by 127 · see citing works
Wang, X., Mao, X., Xie, L., Greenberg, D. A., & Jin, K. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.83 · Cited by 127 · see citing works
Signaling Pathways in Reactive Astrocytes, a Genetic Perspective
Kang, W., & Hébert, J. M. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8163-7 · Cited by 123 · see citing works
Proliferating Reactive Astrocytes Are Regulated by Notch-1 in the Peri-Infarct Area After Stroke
Shimada, I. S., Borders, A., Aronshtam, A., & Spees, J. L. (2011) · Stroke · doi:10.1161/strokeaha.111.623280 · Cited by 118 · see citing works
Luna‐Medina, R., Cortés‐Canteli, M., Sánchez-Galiano, S., Morales-Garcia, J. A., Martı́nez, A., Santos, Á., & Pérez‐Castillo, A. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1004-07.2007 · Cited by 114 · see citing works
The endogenous inhibitor of Akt, CTMP, is critical to ischemia-induced neuronal death
Miyawaki, T., Ofengeim, D., Noh, K., Latuszek-Barrantes, A., Hemmings, B. A., Follenzi, A., & Zukin, R. S. (2009) · Nature Neuroscience · doi:10.1038/nn.2299 · Cited by 108 · see citing works
Preconditioning Suppresses Inflammation in Neonatal Hypoxic Ischemia Via Akt Activation
Yin, W., Signore, A. P., Iwai, M., et al. (2007) · Stroke · doi:10.1161/01.str.0000258102.18836.ca · Cited by 104 · see citing works
Notch1–STAT3–ETB R signaling axis controls reactive astrocyte proliferation after brain injury
LeComte, M. D., Shimada, I. S., Sherwin, C., & Spees, J. L. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501029112 · Cited by 103 · see citing works
Inflammation and gliosis in neurological diseases – clinical implications
Członkowska, A., & Kurkowska‐Jastrzębska, I. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.09.020 · Cited by 89 · see citing works
Sun, H.-S., Xu, B., Chen, W., Xiao, A.-J., Turlova, E., Alibraham, A., Barszczyk, A., Bae, C. Y., Quan, Y., Liu, B.-S., et al. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2014.10.003 · Cited by 78 · see citing works
Self-citationQi, Z., Luo, Y., Liu, X., Wang, R., Zhao, H., Yan, F., Song, Z., Luo, M., & Ji, X. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12016 · Cited by 77 · see citing works
Neuroprotective Effect of Bax-Inhibiting Peptide on Neonatal Brain Injury
Wang, X., Han, W., Du, X., Zhu, C., Carlsson, Y., Mallard, C. E., Jacotot, E. D., & Hagberg, H. (2010) · Stroke · doi:10.1161/strokeaha.110.589051 · Cited by 76 · see citing works
Marine Compound Xyloketal B Reduces Neonatal Hypoxic-Ischemic Brain Injury
Xiao, A.-J., Chen, W., Xu, B., et al. (2014) · Marine Drugs · doi:10.3390/md13010029 · Cited by 62 · see citing works
Caspase-3 Mediates In Part Hippocampal Apoptosis in Sepsis
Comim, C. M., Barichello, T., Grandgirard, D., Dal‐Pizzol, F., Quevedo, J., & Leib, S. L. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8354-x · Cited by 54 · see citing works
Light and Electron Microscopy Study of Glycogen Synthase Kinase-3β in the Mouse Brain
Pérez‐Costas, E., Gandy, J. C., Meléndez‐Ferro, M., Roberts, R. C., & Bijur, G. N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008911 · Cited by 50 · see citing works
D’Angelo, B., Ek, C. J., Sun, Y., Zhu, C., Sandberg, M., & Mallard, C. E. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.09.017 · Cited by 41 · see citing works
Inhibition of GSK-3 reduces infarct volume and improves neurobehavioral functions
Koh, S., Yoo, A., Chang, D., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.05.006 · Cited by 38 · see citing works
Tideglusib protects neural stem cells against NMDA receptor overactivation
Armağan, G., Keser, A., Özkaya, Ç. A., et al. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.01.007 · Cited by 13 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation
Chen, Y., & Yu, Y. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02853-3 · Cited by 516 · see citing works
Role of GSK-3β Inhibitors: New Promises and Opportunities for Alzheimer’s Disease
Shri, S. R., Manandhar, S., Nayak, Y., & Pai, K. S. R. (2023) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2023.071 · Cited by 71 · see citing works
Tau-targeting therapy in Alzheimer’s disease: Critical advances and future opportunities
Guo, Y., Li, S., Zeng, L.-H., & Tan, J. (2022) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2022.16 · Cited by 61 · see citing works
Targeting dementias through cancer kinases inhibition
Fagiani, F., Lanni, C., Racchi, M., & Govoni, S. (2020) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12044 · Cited by 43 · see citing works
Jiang, X., Zhou, J., Wang, Y., Chen, L., Duan, Y., Huang, J., Liu, C., Chen, Y., Liu, W., Sun, H., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112751 · Cited by 39 · see citing works
Self-citation
- Authors
- Wang, H., Huang, S., Yan, K., Fang, X., Abussaud, A., Martinez, A., Sun, H.-S., & Feng, Z.-P.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Sun, Hong-Shuo
- Feng, Zhong-Ping
- Venue
- Biochimica et Biophysica Acta (BBA) - General Subjects
- Publisher
- Elsevier BV
- Published
- 2016-10
- Volume
- 1860
- Issue
- 10
- Pages
- 2076-2085
- ISSN
- 0304-4165 (ISSN-L)
- OpenAlex
- W2467069006
- Cited by
- 59
- References
- 53
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 4 · 2023: 9 · 2022: 8 · 2021: 4 · 2020: 9 · 2019: 6 · 2018: 5 · 2017: 2 · 2016: 1
- FWCI
- 5.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochimica et Biophysica Acta (BBA) - General Subjects (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Sciences and Engineering Research Council of Canada (NSERC-RGPIN 402733)
- ZPF (NSERC-RGPIN 249962)
- Heart and Stroke Foundation of Canada (G-13-0003069)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and fetal brain pathology
- Life Sciences › Neuroscience › Developmental Neuroscience › Anesthesia and Neurotoxicity Research
- Health Sciences › Medicine › Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Keywords
- tideglusib, glycogen synthase kinase-3β inhibition, hypoxic-ischemic brain injury, neonatal stroke, neuroprotection, cerebral infarct volume, Notch1, STAT3 signaling, Akt signaling, caspase-3, caspase-9, glial fibrillary acidic protein, apoptosis, carotid artery ligation
- MeSH terms
- Glycogen Synthase Kinase 3 beta, Animals, Animals, Newborn, Brain Injuries, Disease Models, Animal, Enzyme Inhibitors, Gene Expression Regulation, Humans, Phosphorylation, Thiadiazoles, Signal Transduction, Neuroprotective Agents, Hypoxia-Ischemia, Brain, Proto-Oncogene Proteins c-akt, Mice, Caspase 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
